[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)] [Notices] [Pages 21887-21888] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2020-08269] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-617] Importer of Controlled Substances Application: United States Pharmacopeial Convention ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 20, 2020. Such persons may also file a written request for a hearing on the application on or before May 20, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on March 4, 2020, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, applied to be registered as an importer of the following basic class(es) of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Methamphetamine.......................... 1105 II Cathinone................................ 1235 I Phenmetrazine............................ 1631 II Methylphenidate.......................... 1724 II Amobarbital.............................. 2125 II Pentobarbital............................ 2270 II Secobarbital............................. 2315 II Glutethimide............................. 2550 II Methaqualone............................. 2565 I Lysergic acid diethylamide............... 7315 I 4-Methyl-2,5-dimethoxyamphetamine........ 7395 I 3,4-Methylenedioxyamphetamine............ 7400 I 4-Methoxyamphetamine..................... 7411 I Phencyclidine............................ 7471 II ANPP (4-Anilino-N-phenethyl-4-piperidine) 8333 II Phenylacetone............................ 8501 II Alphaprodine............................. 9010 II Anileridine.............................. 9020 II Cocaine.................................. 9041 II Codeine-N-oxide.......................... 9053 I [[Page 21888]] Dihydrocodeine........................... 9120 II Difenoxin................................ 9168 I Diphenoxylate............................ 9170 II Heroin................................... 9200 I Levomethorphan........................... 9210 II Levorphanol.............................. 9220 II Meperidine............................... 9230 II Dextropropoxyphene, bulk (non-dosage 9273 II forms). Morphine-N-oxide......................... 9307 I Thebaine................................. 9333 II Norlevorphanol........................... 9634 I Oxymorphone.............................. 9652 II Noroxymorphone........................... 9668 II Alfentanil............................... 9737 II Sufentanil............................... 9740 II ------------------------------------------------------------------------ The company plans to import the bulk control substances for distribution of analytical reference standards to its customers for analytical testing of raw materials. William T. McDermott, Assistant Administrator. [FR Doc. 2020-08269 Filed 4-17-20; 8:45 am] BILLING CODE 4410-09-P